BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 10640165)

  • 1. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
    Rahimy MH; Ryan KK
    Contraception; 1999 Oct; 60(4):189-200. PubMed ID: 10640165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women.
    Rahimy MH; Ryan KK; Hopkins NK
    Contraception; 1999 Oct; 60(4):209-14. PubMed ID: 10640167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
    Rahimy MH; Cromie MA; Hopkins NK; Tong DM
    Contraception; 1999 Oct; 60(4):201-8. PubMed ID: 10640166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): a contraceptive method for women in the US and worldwide.
    Kaunitz AM; Mishell DR
    Contraception; 1999 Oct; 60(4):177-8. PubMed ID: 10640163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
    Shulman LP; Oleen-Burkey M; Willke RJ
    Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
    Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
    Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem in Chinese women.
    Zhou XF; Shao QX; Han XJ; Weng LJ; Sang GW
    Contraception; 1998 Jun; 57(6):405-11. PubMed ID: 9693401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group.
    Kaunitz AM; Garceau RJ; Cromie MA
    Contraception; 1999 Oct; 60(4):179-87. PubMed ID: 10640164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics.
    Thurman A; Kimble T; Hall P; Schwartz JL; Archer DF
    Contraception; 2013 Jun; 87(6):738-43. PubMed ID: 23265980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
    Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
    Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
    Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
    J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive.
    Recio R; Garza-Flores J; Schiavon R; Reyes A; Diaz-Sanchez V; Valles V; Luz de la Cruz D; Oropeza G; Perez-Palacios G
    Contraception; 1986 Jun; 33(6):579-89. PubMed ID: 3769482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg).
    Sierra-Ramírez JA; Lara-Ricalde R; Lujan M; Velázquez-Ramírez N; Godínez-Victoria M; Hernádez-Munguía IA; Padilla A; Garza-Flores J
    Contraception; 2011 Dec; 84(6):565-70. PubMed ID: 22078184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive.
    Schiavon R; Benavides S; Oropeza G; Garza-Flores J; Recio R; Díaz-Sanchez V; Pérez-Palacios G
    Contraception; 1988 Jun; 37(6):591-8. PubMed ID: 3396358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
    Jain JK; Ota F; Mishell DR
    Contraception; 2000 Mar; 61(3):195-8. PubMed ID: 10827333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intermittent antiprogestin RU486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation.
    Kekkonen R; Croxatto HB; Lähteenmäki P; Salvatierra AM; Tuominen J
    Hum Reprod; 1995 Feb; 10(2):287-92. PubMed ID: 7769050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraception 2000: lunelle, an injectable combination contraceptive option.
    Shulman LP
    J Womens Health Gend Based Med; 2000 Sep; 9(7):725-9. PubMed ID: 11025864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group.
    Cromie MA; Maile MH; Wajszczuk CP
    Contraception; 2000 Jan; 61(1):51-9. PubMed ID: 10745070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg/0.65 mL) contraceptive formulation in Asian women.
    Toh YC; Jain J; Rahnny MH; Bode FR; Ross D
    Clin Ther; 2004 Nov; 26(11):1845-54. PubMed ID: 15639696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.